Donald Trump May Read Ukraine Call Transcript on Live

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
93
Donald Trump May Read Ukraine Call Transcript on Live Television
< >

GettyImages-1159892609-640x480.jpg

President Donald Trump says he is considering reading the transcript of his summer telephone call with the president of Ukraine on live television to illustrate directly to the American people that no wrongdoing was discussed between the two world leaders.

“This is over a phone call that is a good call,” the president told the Washington Examiner. “At some point, I’m going to sit down, perhaps as a fireside chat on live television, and I will read the transcript of the call, because people have to hear it. When you read it, it’s a straight call.”

President Trump also reiterated to the publication that he has no plans to cooperate with the House Democrats’ partisan impeachment investigation, stating the closed-door proceedings “are setting a terrible precedent for other presidents.”

“Everybody knows I did nothing wrong,” he added. “Bill Clinton did things wrong; Richard Nixon did things wrong. I won’t go back to [Andrew] Johnson because that was a little before my time,” he said. “But they did things wrong. I did nothing wrong.”

Although some witnesses — such as Lt. Col. Alexander Vindman and diplomat Bill Taylor — have expressed concerns about the July 25th call, other officials have said they believe no wrongdoing occurred during the conversation, which included a suggestion by President Trump for Zelensky to examine allegations of corruption against former Vice President Joe Biden and his son, Hunter Biden. House Democrats claim the president appears to have attempted to exchange $400 million in U.S. aid to Ukraine for a probe into the Biden family, a charge both world leaders vehemently deny.

On Thursday, former senior White House official Tim Morrison reportedly testified to congressional investigators that he was not concerned any illegal activities occurred during the call.

“I want to be clear, I was not concerned that anything illegal was discussed,” Morrison, who resigned Wednesday as former National Security Council’s top adviser for Russian and European affairs, told lawmakers, according to The Federalist.

The publication also reported Morrison told lawmakers that Ukrainian officials were unaware that the Trump administration had delayed U.S. military aid to the eastern European country until the end of August 2019 — roughly one month after President Trump’s conversation with Ukrainian President Volodymyr Zelensky.

“I have no reason to believe the Ukrainians had any knowledge of the [military funding] review until August 28, 2019,” Morrison continued.

“I am pleased our process gave the president the confidence he needed to approve the release of the security sector assistance,” he added. “I am proud of what I have been able, in some small way, to help the Trump administration accomplish.”

President Trump’s comments were published just hours after the House approved a resolution that formally authorizes the impeachment investigation.

The lower chamber voted 232-196 in favor of House Resolution 660. The vote split mostly down party lines, with four members abstaining. No Republican voted for the resolution and two Democrats — Reps. Collin Peterson (MN) and Jeff Van Drew (NJ) — voted against the resolution. One independent lawmaker, former Republican Justin Amash (MI), backed the measure.

Among other things, the measure directs “certain committees to continue their ongoing investigations as part of the existing House of Representatives inquiry into whether sufficient grounds exist for the House of Representatives to exercise its constitutional power to impeach Donald John Trump, president of the United States of America, and for other purposes.”

The resolution also enables Republicans to request witnesses and documents, authorize committees to release interview transcripts and outline public hearings. It also allows Trump and White House counsel to attend hearings, question witnesses and recommend additional testimony and evidence.

However, the resolution includes a “loophole” that would give Democrats on the Judiciary Committee the power to reject witnesses requested by the White House. “Under the House Judiciary procedures, Trump and his counsel will be invited to attend all panel proceedings and ask questions. They can also request additional evidence or witness testimony, but the ‘committee shall determine whether the suggested evidence is necessary or desirable,'” notes Roll Call.

Asked about the provision, Nadler told the publication that the rule is a “precaution,” before adding, “I hope we don’t need to use it.”
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

China's Manufacturing: Squeeze or Opportunity?

Updated Category News Views 1

Analyzing China's Impact on Global Markets Think of China's manufacturing clout and you're likely to picture booming factories, relentless steel, and smoke-churning industries reshaping the global chessboard. But here's the kicker: are they swallowing up room for others, or paving the way for their growth? It’s this debate that took the spotlight at the Asia-Pacific...

Continue Reading
Pudu D7 Robot Shines at IFA, Setting New Robotics Bar

Updated Category News Views 2

Breaking New Ground in Robotics at IFA Well, here's a nugget for robotics buffs and investors alike: Pudu Robotics, a heavyweight in commercial service robotics, is carving out a fresh chapter with its PUDU D7. Making waves as an honoree at the IFA Innovation Awards, the D7 presents a mash-up of brains and brawn—exemplifying the future path for robotics. The PUDU D7...

Continue Reading
Changhong's IFA 2026 Showcase: AI, Culture & Localization

Updated Category News Views 3

Changhong's Game Plan: From Global Reach to Local Touch Well, Changhong's not sitting back at IFA 2026, let me tell you that. This isn't your run-of-the-mill showcase; it's a full-on reveal of what happens when a company takes AI tech and tunes it to the heartbeat of daily life. TVs, fridges, air conditioners—you name it, they've got an AI twist on it. But is this just...

Continue Reading
Morpho Unveils Versatile UV Printer at IFA 2026

Updated Category News Views 4

IFA 2026: A New Frontier for Desktop Printing You've seen your fair share of printers over the years, but when a company like Morpho steps onto the scene with a gadget that echoes innovation, it makes you perk up those market-ears. We're talking the big unveil of their desktop UV printer at the IFA 2026 in Berlin. Morpho's contraption isn't just spewing out ink; it's...

Continue Reading
York Space Systems Faces Class Action Over Misleading IPO

Updated Category News Views 2

York Space Systems Under the Legal Spotlight Ever get that feeling when something just doesn’t sit right? Like a burr under the saddle, York Space Systems is now grappling with a class action lawsuit that's throwing a heap of shade on its recent moves. What’s at play? Bronstein, Gewirtz & Grossman, LLC, a law firm that seems to have a nose for corporate messes, has...

Continue Reading
Roborock Fuels Market Surge with 27.6% Revenue Boost

Updated Category News Views 1

Roborock's Rocket-Like Ascent in Global Markets Call me impressed, but Roborock is really hitting its stride. The company's been on a tear, pulling in RMB 10.084 billion during the first half of 2026—a remarkable 27.6% bump from last year. Not just content with the revenue surge, they also saw net profits jump 45.6%, making it pretty clear that they're not just playing...

Continue Reading
Hims & Hers Faces Class Action: Investors Beware

Updated Category News Views 1

Allegations and Legal Pressure There's trouble brewing in the land of health and wellness apps, with Hims & Hers Health, Inc. (NYSE:HIMS) taking center stage. Slap on your glasses, folks, because this one's a doozy. A class-action lawsuit has exploded against the company and some of its officers—allegations flying as they focus on serious accusations of misleading...

Continue Reading
EyePoint Stumbles: Legal Eagles Circle Post-Trial Flop

Updated Category News Views 1

EyePoint Slips on Clinical Banana Peel Well, if EyePoint was aiming for a splash, they sure got it—just not the kind they were hoping for. News dropped like a lead balloon when EyePoint announced their Phase 3 DURAVYU trial results for wet age-related macular degeneration, revealing they missed their primary endpoint. And what did that mean for their stock? A death...

Continue Reading
LiberNovo Demos Ergonomic Seating at IFA 2026

Updated Category News Views 3

Riding the Ergonomic Wave at IFA 2026 No stranger to the innovation spotlight, LiberNovo’s got its eyes on Berlin this time around. As sparks fly at the IFA 2026, they’re rolling out their grand Maxis Series and rubbing shoulders with big names in technology. How does a company shake things up in a sea of tech? Start by thinking big and tall—literally. Maxis Series:...

Continue Reading
See's Candies Data Breach Spurs Legal Scrutiny

Updated Category News Views 12

Data Breach Hits See's Candies Hard Amidst Ransomware Attack Alright, folks, here's a not-so-sweet tale to kick off your day — See's Candies has found itself in a bit of a pickle. A ransomware attack, the nasty kind that makes you double-check your locks and your passwords, has reportedly exposed the personal data of its customers and employees. We're talking names,...

Continue Reading

Top 5 Most Recently Viewed Articles

Hoyne Bancorp's Transition to Stock Holding Company Explained

Updated Category News Views 240

Hoyne Bancorp, Inc. Announces Conversion Approval Hoyne Bancorp, Inc., a leading financial institution, has recently completed a significant milestone in its evolution. This marks an important phase as the organization transitions from a mutual holding company to a stock holding company, a move that is poised to enhance its operational framework. By transforming into a...

Continue Reading
Incyte's INCB123667 Demonstrates Promise for Ovarian Cancer

Updated Category News Views 133

Incyte's Advancements with INCB123667 Incyte, a forward-thinking biopharmaceutical company known for its innovative therapies, has revealed promising early-stage clinical results for its CDK2 inhibitor, INCB123667. This potential game-changer is designed to target advanced solid tumors, particularly ovarian cancer, where there are still significant unmet medical needs....

Continue Reading
GCL SI Highlights Innovations and Solutions for Solar Energy

Updated Category News Views 167

GCL SI Showcases Innovations at Intersolar Europe At Intersolar Europe 2025, GCL System Integration (GCL SI) presents groundbreaking technologies and comprehensive solar solutions, demonstrating its significant role in photovoltaic advancement. From cutting-edge granular silicon to high-efficiency perovskite modules, GCL is at the forefront of global decarbonization...

Continue Reading
8x8, Inc. Celebrates Inclusion in Newsweek's Excellence Ranking

Updated Category News Views 177

8x8, Inc. Recognized by Newsweek for Corporate Excellence 8x8, Inc. (NASDAQ: EGHT) has recently been acknowledged in the prestigious Excellence 1000 Index published by Newsweek. This esteemed ranking celebrates companies demonstrating outstanding practices in various crucial areas such as financial responsibility and social accountability. Understanding the Excellence...

Continue Reading
James Hardie Industries Faces Leadership Change Amid Lawsuit

Updated Category News Views 183

James Hardie Industries Faces Leadership Turmoil Recently, James Hardie Industries plc (NYSE: JHX) announced a significant leadership transition with the departure of its Chief Financial Officer, Rachel Wilson. Ryan Lada has been brought in as her replacement. This change comes in the wake of troubling developments concerning the company's financial practices and investor...

Continue Reading